All News
All news
-
News Watch now: Pharma Trends 2022 Webinar
We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event. -
News Piramal adds antibody CDMO capabilities with investment in Yapan Bio
Transaction adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering -
News SHL Medical publishes its Molly® modular platform technology white paper
This white paper is a retrospective analysis on how the new generation of Molly autoinjectors have incorporated a greater level of flexibility in its design and development model. -
News Arrowhead Pharma purchases land ahead of new manufacturing facility buildout
New campus will support the company as it approaches potential commercialisation of its rapidly progressing clinical candidates -
News Samsung Biologics and AstraZeneca expand manufacturing partnership to include COVID-19 and cancer therapies
CDMO currently manufacturing LAAB combination treatment and will start on cancer immunotherapy product from next year -
News Packaging and Drug Delivery Trends - 5 key learning points for 2022
During the recent CPHI Webinar Packaging & Drug Delivery Trends for 2022 sponsored by Portal Instruments, experts discussed the crucial factors to consider during the development process, such as digitalisation, sustainability and a shift towards self-... -
News Merck KGaA to design manufacturing process for first Nigerian vaccine plant through Innovative Biotech partnership
Merck will design the manufacturing process to help accelerate self-sufficient vaccine development and manufacturing in West Africa -
News Oxford Biomedica and Novartis extend lentiviral vector manufacturing agreement
The new agreement extends to 2028 and allows Oxord Biomedica to work with other potential partners across all CAR-T targets -
News Abu Dhabi and Belgium establish pharma air corridor
The dedicated pharma trade lane will unite key compliant and sector-certified supply chain stakeholders and help Abu Dhabi to strengthen its capabilities as a life sciences hub -
News Roquette to advance drug delivery research with new US Innovation Center
The new facility will focus on the research of excipients for oral dosage forms, drug delivery systems, nutraceutical APIs and innovative pharma ingredients -
News CPHI releases Pharma Trends 2022 report
CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online. -
News Hilleman Labs establishes Singapore's first pilot manufacturing facility for vaccine development
A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries -
News Evolve Biologics to break ground for new manufacturing facility in Texas
The facility will be the first to use Evolve’s innovative PlasmaCap EBA technology to produce plasma-derived therapeutics -
News Adare Pharma acquires oral formulations specialist Frontida BioPharm
The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges -
News Pharma companies research whether vaccines need upgrade to fight Omicron variant
It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness. -
News Sterling Pharma and MIB partner to develop low-cost route to new oral COVID drug
The new route uses a novel enzyme, cytidine aminotransferase, which would reduce the manufacturing cost of the drug -
News Lyophilisation technology improving thermal stability and reducing cycle times, says Recipharm expert
Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm. This is particularly true for those that are thermolabile, such as mRNA ... -
News Lonza signs five-year collaboration deal with VC firm Bioqube to speed up portfolio companies’ development and manufacturing
The offering will accelerate timelines for the development and manufacturing of molecules and disruptive technologies -
News ST Pharm to construct second oligonucleotide facility in Korea
The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025 -
News Hovione to create new campus and 100 jobs at New Jersey site
The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing -
News CPHI Podcast Series: Annual Report 2021 Roundtable
In this special edition podcast, Informa Markets pharma editor Gareth Carpenter speaks to Bikash Chatterjee, CEO at Pharmatech Associates and Dan Stanton, Editor and Founder at BioProcess International about some of the findings in the recently pu... -
News ANI Pharma enhances generics and CDMO business through Novitium acquisition
The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business -
News WuXi Biologics' MFG5 facility completes first GMP production at 24,000-L line
The facility's total 60,000-L capacity supports growing demand for manufacture of late-phase and commercial projects -
News China sees huge bounce in pharma rankings ahead of hybrid CPHI & P-MEC China
China is the pharma industry’s biggest gainer in the 2021 CPHI Annual Rankings, with digital matchmaking driving new waves of partnerships -
News Medinfar awarded first ever CPHI Verified Certificate
CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark -
News BioVectra to build Canada's first mRNA vaccine and biomanufacturing facility
The state-of-the-art centre will be built in Prince Edward Island to support domestic biomanufacturing capabilities -
News Four in 10 patients fear pharma supply chain issues pose risk of illness or death, study finds
New Zebra study shows the pharmaceutical industry has a trust problem, but industry leaders say they’re trying to become more transparent -
News Lonza Switzerland site to undergo expansion of microbial development capabilities
The expansion includes the installation of a pilot suite with a 50-L fermenter and automation upgrades to accelerate clinical and commercial projects -
News CBM secures funding from SK for C&G manufacturing expansion
SK's financial backing enables CBM to address significant capacity constraints in the cell and gene therapy manufacturing space -
News Moderna collaboration set to bring mRNA manufacturing to Australia
The proposed state-of-the-art facility could potentially produce up to 100 million vaccine doses each year for Australians -
News AstraZeneca to transition to ‘modest profitability’ on future COVID-19 vaccine orders
Company says it has concluded virus is in endemic phase and it is the ‘right time’ to switch -
News Hoth Therapeutics and WuXi strike API and drug product deal for cancer therapeutic
WuXi will use its new modality platform to provide an end-to-end solution for oligonucleotide peptide -
News Almac to employ 1,800 people in global recruitment drive
The CDMO will raise its headcount to 8,000 across its 19 global facilities amid increased demand for services -
News 2021 CPHI Pharma Awards winners announced
Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals. -
News Meiji Seika to expand CDMO business with new manufacturing facility in India
The $20.1 million investment will enable the company to manufacture pharma products for the Adcock Ingram Group and for other clients -
News Cannabics Pharmaceuticals and Purisys sign cannabinoid API supply agreement
The transaction will support Cannabics' planned IND fillings and Phase I/II (a) clinical trials -
News PCI Pharma Services to build Clinical Supply Centre of Excellence in New England
The first-of-its-kind centre will offer biopharma clients convenience and efficiencies in the rapidly expanding Northeast -
News Early development demand continues to boost prospects for smaller CDMOs: CPHI Worldwide panel
The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market -
News Viral vector demand to flourish on wave of imminent approvals, CPHI Worldwide audience told
Expected increase in approvals for gene therapies, gene-modified cell therapies and recombinant vector vaccines will also increase pressure on manufacturers to build new capacity -
News Flamma USA opens doors to HPAPI suite
The CDMO says the suite will help to "bring back manufacturing to the US" -
News Lonza boosts exosome capability with Codiak BioSciences facility acquisition
The companies will establish a Centre of Excellence focused on exosome manufacturing and characterization technologies -
Sponsored Content CPHI Webinar: Early multi-functional approach is the best way to incorporate patient centricity into drug formulations
The concept of patient centricity has many nuances, and designing dosage forms needs to be underpinned by a multi-functional perspective utilised as early as possible, say experts -
News BioProcess International webinar series to focus on optimising biologics manufacturing
Upcoming Late Stage Bioprocessing & Viral Vectors Digital Week running 2-11 November will address many goals and challenges associated with optimizing biologics manufacturing through different stages of the process -
News CPHI Worldwide is back, and this time it’s hybrid
A new in-person and online edition of CPHI Worldwide, transforming your event experience. -
News SGS completes expansion of its Biosafety Centre of Excellence in Glasgow
Clients to receive accelerated quality testing and reduced turnaround times -
News Pharmapack 2021 Packaging and Drug Delivery Trend Report: Out Now!
Rather than looking back at what has been a challenging past few months, this Trend Report - featuring highlights from the Pharmapack 2021 content programme - has been written very much in the spirit of looking forward and addressing the key challenges... -
News Increasing demand for outsourced manufacturing due to changing Chinese market conditions, CPHI Worldwide conference told
Rise of innovative companies with high-risk portfolios will necessitate need for CDMOs, says Thermo Fisher senior executive -
News Catalent embarks on $230M viral vector expansion project at Harmans campus
By completion at the end of 2022, the campus will accommodate 18 cGMP viral vector manufacturing suites -
News API supply chain needs to address future challenges arising from China situation: CPHI Worldwide panel
COVID-19 pandemic has exposed weaknesses and sector faces new challenges driven by rising costs of production in China -
News Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages
Current EU regulatory systems too overwhelmed by paper, head of European association representing generics, biosimilars and value added medicines industries tells CPHI Worldwide online conference -
News Indian pharma industry on cusp of growth spurt, CPHI Worldwide audience told
Country expected to grow threefold over the next decade due to increased focus on complex generics, biosimilars and specialty products -
News GTP Bioways to galvanise CDMO position in France with two new biopharma facilities
One site will focus on microbial production, the other on small-scale mammalian-based production -
News Next stop, Milan - Welcome to Italy's life sciences hub
Milan is home to an internationally competitive pharmaceutical, biotechnology and functional foods hub, with strong growth prospects and a commitment to innovation across its entire supply chain. Italy is also home to one of the most advanced and ... -
News Alcami to manufacture PharmaTher’s proprietary ketamine products
The CDMO will supply expertise in GMP sterile fill-finish manufacturing and controlled-substances -
News Phlow receives approval to join BARDA CDMO network
As a network member, the company hopes to help reduce the US's reliance on overseas imports by providing domestic API capability -
News Novavax defends COVID-19 vaccine manufacturing processes after claims of quality issues
According to unnamed sources in Politico report, company’s vaccine batches have not met FDA purity level standards -
News FDA misses approval target dates after plant inspections delayed by COVID travel restrictions
UCB Pharma is informed by agency that action on application for psoriasis treatment is being deferred until on-site visits can be made -
News FDA declines approval of United Therapeutics’ Tyvaso after inspection issue
In complete response letter, agency cites single deficiency at third-party facility that performs analytical testing of Treprostinil drug substance -
News Matica Bio and Sartorius form large-scale vector production research pact
Together the companies will attempt to overcome "black box" challenges to enable more robust and consistent results for clients -
News China SXT's new lyophilisation facility secures pharmaceutical manufacturing permit
The move, coupled with the plants's passing of a pharmaceutical GMP compliance inspection, will enable company to accelerate the R&D of its novel Advanced TCMPs -
News Avid Bioservices to plug capacity gap with new viral vector manufacturing facility
The biologics CDMO says it expects its new 53,000-sq.ft facility will be operational within 18 months -
News Everest Organics starts API production for Merck anti-COVID pill
Manufacturer starts development of API for molnupiravir, which is set to become world’s first oral treatment against coronavirus -
News Pharmapack Europe 2021 announces Awards winners!
Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories -
News Pharmapack 2021: Barriers to healthcare adoption of growing sustainable packaging trend still exist, say experts
Panel discusses how healthcare institutions are adapting to calls for more sustainability in various processes in the value chain -
News Aceto boosts biomanufacturing footprint with acquisition of Ireland-based A&C Bio Buffer
The transaction expands the CDMO's GMP biopharmaceutical and vaccine manufacturing capabilities -
News Merck KGaA doubles gene therapy capacity with opening of second Carlsbad CDMO facility
The new the 140,000-sq. ft facility will support commercialisation and industrialisation of viral vectors -
News Eckert & Ziegler expands CDMO services to support radiopharma companies
Having acquired a 53,000 sq-ft property in Berlin, the company plans to set up new laboratories, production and cleanrooms -
News CPHI Webinar: mRNA vaccines, Trends, Technologies and Supply Chain
The COVID-19 pandemic has meant scientists, together with pharmaceutical companies, have had to reinvent how to bring vaccines to market faster without impacting product quality, safety, or efficacy, according to experts speaking at a recent CPHI webin... -
News Pharmapack 2021: Pre-filled syringe technology could provide answers to future mass vaccination challenges, says BD
Pre-filled syringes (PFS) could help immensely in solving the challenges of rolling out future mass vaccination campaigns, according to experts at Becton Dickinson (BD). -
News Pharmapack 2021: Increasing connectivity is the key to patient centricity and simplified access to product information
During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device... -
News Boehringer opens doors to new Austrian biopharma production site
The LSCC provides an additional 30% in mammalian large-scale capacity for the company's own pipeline and for third parties -
News COVID-19 triggers growing interest of European patients in where drugs are manufactured: Teva study
Just as 'food miles' have become a key concern among consumers in recent years, patients now want to know more about 'medicine miles', study commissioned by Teva finds -
News Pharmapack 2021: Convergence of trends are pushing drug delivery devices towards connectivity, says Nemera
Electronic devices and connectivity are being progressively included in drug delivery devices, bringing positive outcomes to all stakeholders, according to drug device combinations specialist, Nemera Tuesday -
News Pharmapack 2021: Traceability of medicines can transform pharma supply chain, delegates told
Traceability of medicines can help to reduce the negative effects to pharmaceutical supply chains of counterfeit medicines, medication errors and drug shortages, Nathalie Wardé-Dunoyer, CEO & Founder of Swiss start-up, D4P pharma told the Pharma... -
News Iovance opens PA cell therapy plant in Philadelphia
The $85 million Iovance Cell Therapy Center (ICTC) has opened its doors at the Philadelphia Navy Yard with capacity to supply thousands of patients per year. -
News Advanced Computing in Pharma: 3 reasons why quantum computing could disrupt R&D
Quantum computing technology uses quantum systems called “qubits”. They work with non-binary values, unlike classical computing which uses only bits with values of 0 or 1, and can overlap each other and act as a group. The result is a ... -
Sponsored Content Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California
Responding to critical market capacity constraints, Thermo Fisher announces the official opening of new 67,000 sqft cGMP plasmid DNA manufacturing facility in Carlsbad, CA. This site expands clinical and commercial capabilities for cGMP plasmid DNA use... -
News Thermo Fisher takes on operational responsibility for new Swiss biologics manufacturing site
The 1.5 million-sq. ft Switzerland-based facility is part of the company's strategic partnership with CSL Limited -
News Forge Biologics to provide CDMO support for Solid Biosciences' preclinical gene therapy
By providing AAV process development, scale up and cGMP manufacturing services, Forge hopes to bolster Solid's gene therapy pipeline -
News MannKind signs sale-leaseback agreement for inhaled insulin manufacturing site
The transaction will generate $102.25 million to support the company's product pipeline and scaling up commercial activities for Afrezza -
News Greenfield Global Ireland Ready to Supply Life Science Customers Globally
New facility aims to serve local and global pharmaceutical customers with high-purity ethanol, ethanol blends and buffer solutions -
Sponsored Content IFF Pharma Solutions: Paving the Way for Superior Suspensions
Shawn Branning, Global Strategic Marketing Manager at IFF – Pharma Solutions -
Sponsored Content CPHI Webinar: Develop ODTs in a FLASH with UltraBurst™ - Watch On Demand
Catch up on the latest trends and developments in orally disintegrating tablet (ODT) formulation development -
Sponsored Content Biocatalysis: An Indispensable Tool for Synthesis of Active Pharmaceutical Ingredients
Biocatalytic processing offers a wealth of advantages and should be evaluated during early-stage drug development for its potential to improve yields, increase efficiency, and support greener manufacturing. -
News Fujifilm begins commissioning phase of new Netherlands-based manufacturing facility
The facility will increase the production capacity of cell culture media products and provide a hub for European and global markets -
News Rare diseases care pathway: a major challenge to harmonize patient management
In France, rare diseases are numerous: between 7,000 and 8,000 diseases are currently accounted for, and concern more than 3 million French people, accounting for almost 4,5% of the total population. The organization of screening and care for these ill... -
News Sartorius to add flagship site in North America
The company plans to open a new 130,000-sq. ft plant in Ann Arbor in late 2023 -
News Hikma boosts US injectables business with $425 million deal for Custopharm
The acquisition will add 13 approved products and additional pipeline products -
News Report accuses Covid vaccine makers of putting profits before lives
Only 0.3% of the 5.76 billion doses administered worldwide have been distributed to low-income countries -
News SK Capital Partners in discussions to create an integrated global API CDMO leader
The private investment firm plans to acquire SEQENS and merge it with Wavelength Pharmaceuticals -
News 5 Highlights from the Pharmapack Europe Content Programme
Pharmapack Europe is back! Join us online from 27 September as we kick off our two-week long content programme, a great precursor to the in-person event from 13-14 October at the Paris Expo Porte de Versailles. -
News Recro Pharma backs sustainability programme with 'green' energy transaction
The agreement will contribute toward the equivalent reduction of 937,426 tons of carbon dioxide emissions -
News Fresenius Kabi invests in Pre-Filled Syringe Capacities for US and EU supply
As a safe, effective and convenient way to administer injectable medications, pre-filled syringes (PFS) have become the injection system of choice for a growing number of drugs. PFS allow healthcare professionals to easily handle syringes, reduce waste... -
News New Thermo system makes AAV production more efficient and scalable
The company's new Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline transition from research to clinical environments -
News Catalent and Phathom Pharmaceuticals strike commercial supply agreement
The CDMO will provide commercial manufacturing and packaging services for Phathom's novel, orally active P-CAB -
News Catalent boosts nutraceuticals market presence with $1 billion Bettera acquisition
The transaction is expected to accelerate Catalent's growth in global softgel and oral dose formulation and manufacturing services -
News Introducing the all-new CPHI Online dashboard
Today, Informa Markets is pleased to announce the launch of the all-new CPHI Online Dashboard, which will allow CPHI clients to quickly and easily track awareness and interest in their company, products and content as well as view and download leads to... -
News Clean Cells to invest €13 million to create Europe's largest cell bank production site
The expansion is anticipated to speed up development and time-to-market of novel treatments and vaccines for COVID‑19 -
News AGC Biologics to increase capacity for pDNA and mRNA manufacturing in Heidelberg
The expansion plans include an additional manufacturing line, a new cleanroom and a new process development lab -
News Room for specialists and one-stop-shops in CDMO space
As CDMOs seek to diversify their business models, is a full-service offering the holy grail or is there a danger of biopharmaceutical outsourcing firms becoming the jack of all trades and the master of none? -
News Recro and BioCorRx expand partnership for OUD treatment
The CDMO, through its recent acquisition of IsiSys, will help to advance BICX104 toward first-in-human clinical trials -
News Olon to combine protein production expansion with sustainability
The new area will produce proteins using innovative and highly sustainable processes such as microbial fermentation -
News Thermo Fisher to build facility in Nashville for production of single-use technologies products
Investment will further expand CDMO's global network of SUT facilities to boost reliable supply of critical materials used to produce new biologics and vaccines -
Sponsored Content CPHI Podcast Series: Selecting the Right CDMO Outsourcing Partner
Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector, gaining access to manufacturing capacity and state-of-the-art equipment and... -
News Emerging regional markets show promise as CDMO globalisation trend grows
Opportunities for CDMO expansion are extending to Latin America and Africa, say experts -
News GenScript ProBio to manufacture clinical trial batches of Synimmune's lead antibody drug
The CDMO will manufacture drug substance and drug product for Phase II clinical trials in AML patients -
News Takeda to supply Japan with 150 million doses of Novavax COVID vaccine
Japan's biggest drugmaker prepares to make the vaccine domestically and anticipates early 2022 distribution -
Sponsored Content Clinical & Commercial Drug Product Manufacturing: Outsourcing Advice from a CDMO
Taking a sterile drug product from clinical to commercial scale brings unique challenges. In this article, LLS Health investigates ways to mitigate scale-up challenges and achieve success. -
News Formulated Solutions completes investment and expansion project
The CDMO significantly increases its footprint, capacity and capabilities to meet current and future demand -
News 3i Group backs ten23 health to create global CDMO focused on biopharma injectables
The new Switzerland-based CDMO differentiates itself by its sustainable vision of making a positive impact for people and planet -
News Thermo Fisher Scientific and AstraZeneca sign NGS-based CDx co-development agreement
Companies say earlier collaboration may speed development and introduction of targeted precision medicine therapies for patients. -
News Reopened USAntibiotics penicillin facility to relieve US dependence on Chinese antibiotics: Jackson Healthcare
The facility will be able to manufacture and stockpile a five-year supply of amoxicillin for the US -
Sponsored Content Sterile manufacturing Annex 1 amendments: what, why and how explained
In January 2020 the European Commission published some proposed significant revisions to Annex 1, the EU’s good manufacturing practice (GMP) guide for the manufacture of sterile products. In the following three-month consultation period, affected... -
News Cipla and Kemwell to form joint venture targeting respiratory biosimilars market
The agreement is expected to accelerate Cipla’s global lung leadership agenda -
News Medicines Manufacturing Innovation Centre aims to 'solve major pharma industry challenges'
£35 million public-private collaboration to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain -
News Recipharm expands its analytical services offering in India
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions -
News Signature Biologics opens additional manufacturing and R&D facility
The new facility will augment the company's capacity to broaden its portfolio of perinatal-derived products -
News Pfizer-BioNTech shot becomes first COVID-19 vaccine to gain full FDA approval
Pfizer and BioNTech’s shot on Monday became the first COVID-19 vaccine to be granted full approval by the US Food and Drug Administration. -
News Lonza to establish multi-product fill and finish line in China
The new production line at Guangzhou site will supply global and domestic companies with clinical and commercial batches -
News Responsible Supply Chain Practices: Highlights from the PSCI Annual Report
An update on responsible supply chain management from the Pharmaceutical Supply Chain Initiative Chair, Manjit Singh
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance